loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 204057 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ETHINYL ESTRADIOL; NORGESTIMATE (1)

filter

01 GLENMARK PHARMS (1)

filter

01 TABLET;ORAL-28 (1)

filter

01 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG (1)

filter

01 USA (1)

URL Supplier Web Content
TABLET;ORAL-28
0.025MG,0.025MG,0.025M...
NORGESTIMATE AND ETHIN...
USA
204057
2016-02-23
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 204057

Looking for CTD TGA MCC DOSSIER APPLICATION 204057 1

19

Glenmark Pharmaceuticals, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is ETHINYL ESTRADIOL; NORGESTIMATE, with a corresponding application number 204057 and regulatory information .

proudly manufactured in the

approval since 2016-02-23

Glenmark Pharmaceuticals's NORGESTIMATE AND ETHINYL ESTRADIOL TABLET;ORAL-28, medication with 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG of ETHINYL ESTRADIOL; NORGESTIMATE.

Post Enquiry
POST ENQUIRY